figshare
Browse
pone.0257551.s007.docx (21.21 kB)

Re-Cx regimens (30 cases) classified according to the molecular targeted agents.

Download (21.21 kB)
journal contribution
posted on 2021-09-24, 17:29 authored by Masashi Ishikawa, Atsuo Takashima, Yusuke Nagata, Ryoichi Sawada, Masahiko Aoki, Hiroshi Imazeki, Hidekazu Hirano, Hirokazu Shoji, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Ken Kato, Masayuki Saruta, Narikazu Boku

(DOCX)

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    results also suggestedobjective response ratemetastatic colorectal cancer18 cases ),tumor growth ratedisease control rateretrospective study evaluatedindicates tumor shrinkage8 cases ),3 cases ).previously used agentstumor shrinkage30 cases12 casesdisease progressionxlink ">tumor efficacysalvage treatmentoxaliplatin basedoverall survivaloctober 2018occasionally reusednovember 2011median progressionmeasurable lesionsmcrc ).free survivaldiscontinued dueclinical practicechemotherapeutic agents87 %).57 months3 %).25 patients

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC